Bayer applies artificial intelligence to medical cases

Adverse drug reactions or adverse drug events refer to unwanted or harmful reactions experienced following the administration of a medicine or combination of medicines under normal conditions of use. A clinician or patient then suspects the reaction, such as rash or a headache, to be linked to the drug. The event is reported back to the manufacturer of the medicine for investigation and be subject to scrutiny by a regulatory agency, such as the U.S. Food and Drug Administration (FDA). The practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse reactions is referred to as pharmacovigilance, and monitoring is an activity incumbent upon drug manufacturers. The process is also designed to support public health programs by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.